Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Isotype Controls and Standards
  5. BDB552991

anti-IgG2b, κ, PerCP, Clone: A95-1, BD

Catalog No. BDB552991 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB552991 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB552991 Supplier BD Biosciences Supplier No. 552991
Add to Cart
Add to Cart

Description

The A95-1 antibody has unknown specificity. Trinitrophenal (TNP), the immunogen, is a hapten not expressed on human, mouse, rat, or non-human primate cells. The A95-1 immunoglobulin was selected as an isotype control following screening for low background on a variety of mouse and human tissues. This antibody is routinely tested by flow cytometric analysis. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.

Host Species: Rat
Clone: A95-1
Isotype: IgG2b κ
Immunogen: TNP-Keyhole Limpet Hemocyanin

Control, Flow Cytometry

TRUSTED_SUSTAINABILITY

Specifications

Antigen IgG2b κ
Classification Monoclonal
Clone A95-1
Concentration 0.2mg/mL
Conjugate PerCP
Host Species Rat
Immunogen TNP-Keyhole Limpet Hemocyanin
Quantity 0.1 mg
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.